
401PDGEINO 1402: A phase Ib dose-escalation study followed by an extension phase to evaluate safety and efficacy of crizotinib in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma (GB)
Martinez Garcia, M, Gil, M J, Pineda, E, Martin Soberón, M C, Mesia Barroso, C, Foro, P, Capellades, J, Sarmiento, B, Bruna, J, Verger, E, Taus Garcia, A, Alameda, F, Hernandez Lain, A, Velasco, G, SeVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz243.011
Date:
October, 2019
Fichier:
PDF, 78 KB
2019